A Study of Enlicitide Decanoate (MK-0616) and Semaglutide in Healthy Adult Participants (MK-0616-023)

NCT06699329 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Enlicitide Decanoate
DRUG: Semaglutide

Sponsor

Merck Sharp & Dohme LLC